Abivax S.A. (ABVX): key financial figures for fiscal year 2025 (in EUR), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2025)

€4.6M

Net Income/Loss (FY2025)

-€336.1M

Total Assets (FY2025)

€584.3M

Total Equity (FY2025)

€455.2M

Cash Flows from Operating Activities (FY2025)

-€161.1M

Source: Abivax S.A. 20-F filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.